The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
Official Title: Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2
Study ID: NCT04084249
Brief Summary: IMPROVE-IT2 is a randomized multicenter trial comparing the outcomes of ctDNA guided post-operative surveillance and standard-of-care CT-scan surveillance. The hypothesis of this study is that ctDNA guided post-operative surveillance combining ctDNA and radiological assessments could result in earlier detection of recurrent disease and identify more patients eligible for curative treatment.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Surgical Department, Randers Regional Hospital, Randers, , Denmark
Name: Claus L Andersen, PhD
Affiliation: Department of Molecular Medicin, Aarhus University Hospital
Role: PRINCIPAL_INVESTIGATOR